Prostate magnetic resonance imaging: challenges of implementation.
暂无分享,去创建一个
Cary Siegel | Kathryn J Fowler | J. Ippolito | V. Narra | Ronald Loch | Kathryn Fowler | Ryan Schmidt | Joseph Ippolito | Vamsi Narra | C. Siegel | Ryan Schmidt | Ronald Loch
[1] Andrew B Rosenkrantz,et al. Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI. , 2014, AJR. American journal of roentgenology.
[2] Jelle O. Barentsz,et al. Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal–pelvic phased-array coils , 2007, European Radiology.
[3] Yuri Kitamura,et al. Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. , 2006, AJR. American journal of roentgenology.
[4] P. Carroll,et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. , 1994, Radiology.
[5] P. Corso,et al. National Institutes of Health State-of-the-Science Conference , 2012 .
[6] T. Gomes,et al. National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. , 2012 .
[7] Masoom A Haider,et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.
[8] A. Villers. Words of wisdom. Re: Improving detection of clinically significant prostate cancer: MRI/TRUS fusion-guided prostate biopsy. , 2014, European urology.
[9] Diffusionsgewichtete MRT der Prostata , 2011, Der Radiologe.
[10] P. Choyke,et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.
[11] B. Carey,et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.
[12] M. Sumura,et al. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer , 2008, Acta radiologica.
[13] H. Hricak,et al. Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer. , 2012, Radiology.
[14] P. Mozer,et al. Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. , 2012, European urology.
[15] D. Corle,et al. Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study. , 1995, Scandinavian journal of urology and nephrology. Supplementum.
[16] C. Pan,et al. Comparative analysis of sampling methods for grossing radical prostatectomy specimens performed for nonpalpable (stage T1c) prostatic adenocarcinoma. , 2001, Human pathology.
[17] J. Fütterer,et al. Value of 3-T Multiparametric Magnetic Resonance Imaging and Magnetic Resonance–Guided Biopsy for Early Risk Restratification in Active Surveillance of Low-Risk Prostate Cancer: A Prospective Multicenter Cohort Study , 2014, Investigative radiology.
[18] Wei Huang,et al. Signal-to-noise ratio, contrast-to-noise ratio and pharmacokinetic modeling considerations in dynamic contrast-enhanced magnetic resonance imaging. , 2012, Magnetic resonance imaging.
[19] Koon Ho Rha,et al. Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: preliminary analysis. , 2013, The Journal of urology.
[20] A. Jemal,et al. Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[21] Thomas Hambrock,et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.
[22] P. Choyke,et al. Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? , 2013, The Journal of urology.
[23] K. Kihara,et al. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. , 2013, The Journal of urology.
[24] Hans Garmo,et al. Radical prostatectomy versus watchful waiting in early prostate cancer. , 2005, The New England journal of medicine.
[25] Peter C Albertsen,et al. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. , 2009, Journal of the National Cancer Institute.
[26] Baris Turkbey,et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.
[27] C Allen,et al. Prostate MRI: who, when, and how? Report from a UK consensus meeting. , 2013, Clinical radiology.
[28] Gaelle Fiard,et al. Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion. , 2013, Urology.
[29] H Alberto Vargas,et al. Diffusion-weighted MRI of the prostate at 3.0 T: comparison of endorectal coil (ERC) MRI and phased-array coil (PAC) MRI-The impact of SNR on ADC measurement. , 2013, European journal of radiology.
[30] H. Hricak,et al. Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. , 2012, Radiology.
[31] D. Dearnaley,et al. A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance. , 2009, European urology.
[32] François Cornud,et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2‐weighted, dynamic contrast‐enhanced and diffusion‐weighted imaging , 2011, BJU international.
[33] J. Babb,et al. Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI. , 2013, AJR. American journal of roentgenology.
[34] Thomas Hambrock,et al. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. , 2013, Radiology.
[35] Chris Metcalfe,et al. Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study , 2012, BMJ : British Medical Journal.
[36] Javier Hernandez,et al. Prostate MRI: access to and current practice of prostate MRI in the United States. , 2014, Journal of the American College of Radiology : JACR.
[37] C. Kim,et al. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. , 2010, AJR. American journal of roentgenology.
[38] J. Fütterer,et al. ESUR prostate MR guidelines 2012 , 2012, European Radiology.
[39] B. Hamm,et al. Evaluation of the Prostate Imaging Reporting and Data System for the Detection of Prostate Cancer by the Results of Targeted Biopsy of the Prostate , 2014, Investigative radiology.
[40] Baris Turkbey,et al. Comparison of endorectal coil and nonendorectal coil T2W and diffusion‐weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole‐mount histopathology , 2014, Journal of magnetic resonance imaging : JMRI.
[41] Gary Liney,et al. Correlation of diffusion‐weighted magnetic resonance data with cellularity in prostate cancer , 2009, BJU international.
[42] Aytekin Oto,et al. Apparent diffusion coefficient for prostate cancer imaging: impact of B values. , 2014, AJR. American journal of roentgenology.
[43] P. Choyke,et al. Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer , 2013, Cancer.
[44] H. Hricak,et al. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. , 2008, Radiology.
[45] J. Babb,et al. Diffusion‐weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection , 2013, Journal of magnetic resonance imaging : JMRI.
[46] D. Beyersdorff,et al. MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging. , 2005, AJR. American journal of roentgenology.
[47] Baris Turkbey,et al. Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. , 2012, AJR. American journal of roentgenology.
[48] Deanna L Langer,et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. , 2008, Radiology.
[49] Wei Huang,et al. A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings. , 2012, Magnetic resonance imaging.
[50] Evis Sala,et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. , 2006, Radiology.
[51] Timothy J Wilt,et al. Radical prostatectomy versus observation for localized prostate cancer. , 2012, The New England journal of medicine.
[52] T. Wilt,et al. Screening for prostate cancer. , 2013, The Cochrane database of systematic reviews.
[53] Y. Yamashita,et al. Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation , 2010, European Radiology.
[54] Baris Turkbey,et al. Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? , 2013, Radiology.
[55] J. Babb,et al. Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. , 2013, Radiology.
[56] P. Albers,et al. Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard , 2013, European Radiology.
[57] Takeshi Yoshikawa,et al. Clinical utility of apparent diffusion coefficient values obtained using high b‐value when diagnosing prostate cancer using 3 tesla MRI: Comparison between ultra‐high b‐value (2000 s/mm2) and standard high b‐value (1000 s/mm2) , 2012, Journal of magnetic resonance imaging : JMRI.
[58] A. Okuyama,et al. Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging , 2002, European Radiology.
[59] Baris Turkbey,et al. Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. , 2014, The Journal of urology.
[60] A. Evans,et al. Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[61] Fang-Ming Deng,et al. Prostate cancer: comparison of dynamic contrast-enhanced MRI techniques for localization of peripheral zone tumor. , 2013, AJR. American journal of roentgenology.
[62] V. Moyer,et al. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.
[63] Thomas Hambrock,et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance. , 2007, Radiology.
[64] G. Ligabue,et al. Comparative Evaluation Between External Phased Array Coil at 3 T and Endorectal Coil at 1.5 T: Preliminary Results , 2006, Journal of computer assisted tomography.
[65] David Chia,et al. Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.
[66] Aytekin Oto,et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2010, Radiology.
[67] B. K. Park,et al. Comparison of Phased-Array 3.0-T and Endorectal 1.5-T Magnetic Resonance Imaging in the Evaluation of Local Staging Accuracy for Prostate Cancer , 2007, Journal of computer assisted tomography.
[68] Thomas Hambrock,et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.